Pnc Financial Services Group, Inc. Fibrogen Inc Transaction History

Pnc Financial Services Group, Inc.

$148 Billion
Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Fibrogen Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 603 shares of FGEN stock, worth $277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

603

Previous 603 -0.0%

Holding current value

$277

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.38 - $0.91 $203 - $487	-536 Reduced 47.06%	603 $0
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $899 - $3,223	1,139 New	1,139 $0
Q2 2022 Aug 12, 2022	SELL	$7.94 - $12.96 $1,024 - $1,671	-129 Reduced 97.73%	3 $0
Q1 2022 May 12, 2022	BUY	$12.02 - $16.79 $1,490 - $2,081	124 Added 1550.0%	132 $1,000
Q3 2021 Nov 05, 2021	SELL	$10.18 - $26.64 $162 - $426	-16 Reduced 66.67%	8 $0
Q2 2021 Aug 06, 2021	BUY	$18.57 - $35.68 $92 - $178	5 Added 26.32%	24 $0
Q1 2021 May 07, 2021	SELL	$31.0 - $55.72 $218,147 - $392,101	-7,037 Reduced 99.73%	19 $0
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $145,392 - $191,962	3,920 Added 125.0%	7,056 $261,000
Q3 2020 Nov 06, 2020	BUY	$40.47 - $45.5 $125,537 - $141,141	3,102 Added 9123.53%	3,136 $128,000
Q2 2020 Aug 07, 2020	BUY	$32.57 - $42.83 $260 - $342	8 Added 30.77%	34 $1,000
Q1 2020 May 08, 2020	BUY	$23.3 - $45.96 $326 - $643	14 Added 116.67%	26 $0
Q4 2019 Feb 07, 2020	SELL	$34.58 - $48.06 $146,722 - $203,918	-4,243 Reduced 99.72%	12 $0
Q3 2019 Nov 08, 2019	BUY	$36.98 - $48.45 $5,583 - $7,315	151 Added 3.68%	4,255 $157,000
Q2 2019 Aug 09, 2019	BUY	$35.13 - $55.53 $142,733 - $225,618	4,063 Added 9909.76%	4,104 $0
Q1 2019 May 10, 2019	BUY	$42.83 - $59.91 $556 - $778	13 Added 46.43%	41 $0
Q4 2018 Feb 08, 2019	SELL	$37.97 - $60.16 $94,051 - $149,016	-2,477 Reduced 98.88%	28 $1,000
Q3 2018 Nov 09, 2018	SELL	$56.3 - $67.25 $10,077 - $12,037	-179 Reduced 6.67%	2,505 $0
Q2 2018 Aug 10, 2018	SELL	$44.9 - $64.95 $1.18 Million - $1.7 Million	-26,235 Reduced 90.72%	2,684 $0
Q1 2018 May 11, 2018	BUY	$45.35 - $61.65 $1.31 Million - $1.78 Million	28,882 Added 78059.46%	28,919 $0
Q4 2017 Feb 09, 2018	BUY	$41.95 - $60.1 $503 - $721	12 Added 48.0%	37 $0
Q3 2017 Nov 13, 2017	BUY	$33.4 - $53.9 $835 - $1,347	25	25 $0

Others Institutions Holding FGEN

# of Institutions

Shares Held

38.6M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $43.1M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Fibrogen Inc Transaction History